Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
The phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Vimta Labs has reported total income of Rs. 99.31 crores during the period ended June 30, 2025
Loteprednol Etabonate Ophthalmic Suspension, 0.5% is indicated for the treatment of steroidresponsive inflammatory conditions of the palpebral and bulbar conjunctiva
This marks the fourth acquisition by Corona Remedies from multinational corporations
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Subscribe To Our Newsletter & Stay Updated
